Price:
Rs. 20,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: G0108
Frequently Asked Questions (FAQ's):
What does the Dravet Syndrome (SCN1A) Gene Panel test detect?
It identifies mutations in the SCN1A gene associated with Dravet syndrome using advanced NGS at Metropolis Healthcare.
Why is this test important for children with seizures?
It provides an early and accurate genetic diagnosis in infants with recurrent febrile or afebrile seizures.
What sample is required for this test?
EDTA blood is used for DNA extraction and sequencing.
Who should undergo this test?
Infants and young children with drug-resistant epilepsy, prolonged seizures, or developmental regression.
How does Metropolis Healthcare perform this analysis?
Metropolis uses high-coverage NGS technology to detect single-nucleotide variants and small insertions/deletions in SCN1A.
Can this test guide treatment?
Yes, identifying the mutation helps in selecting appropriate antiepileptic drugs and avoiding sodium-channel blockers.
How long does the testing process take?
Turnaround time depends on the workflow, but Metropolis Healthcare ensures timely and accurate reporting.
Is genetic counselling recommended after this test?
Yes, counselling helps families understand inheritance, prognosis, and future planning